No Data
Shengnuo Medicine-B (02257.HK): Dr. Lu Yang stepped down from the honorary scientific advisor position.
On April 23, Gelonghui reported that Dr. Lu Yang has resigned as the Group's Honorary Scientific Advisor, effective from April 23, 2025. The Board of Directors has further resolved that Dr. Lu will resign from (i) all positions at Shennuo Biomedical Technology (Guangzhou) Co., Ltd. and Shennuo Biomedical Technology (Suzhou) Co., Ltd., effective from April 23, 2025, and (ii) all positions at Sirnaomics, Inc., effective from May 22, 2025. After his resignation, Dr. Lu will no longer hold any position within the Group.
Express News | Sirnaomics FY Net Income USD -50.2 Million
SIRNAOMICS-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Saint Noble Medical-B (02257.HK) will hold a Board of Directors meeting on March 27 to approve the annual performance.
Gelonghui, March 17th丨Saint诺医药-B (02257.HK) announced that the Board of Directors meeting will be held on March 27, 2025, to approve the release of the annual performance announcement of the company and its subsidiaries for the year ending December 31, 2024.
SIRNAOMICS-B: NOTICE OF BOARD MEETING
Saint Noble Pharmaceutical-B (02257): Cheng Hai has been appointed as a member of the Audit Committee.
Saint Noble Pharmaceuticals-B (02257) announced that Chang Hai has been appointed as the independent non-executive Director of the company to review...
Press Release: Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer
